Adaptive Biotechnologies Corp 10-Q filing
Filed 2026-05-05 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001193125-26-206546
- Form type
- 10-Q
- CIK
- 0001478320
- Primary document
- https://www.sec.gov/Archives/edgar/data/1478320/000119312526206546/adpt-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Adaptive Biotechnologies Corp.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $70.9M | - | - |
| Cost Of Revenue | $18.7M | - | - |
| Operating Income | $-19.2M | - | - |
| Net Income | $-20.0M | - | - |
| Eps Basic | -0.13 | - | - |
| Eps Diluted | -0.13 | - | - |
| Cash And Equivalents | $77.6M | - | - |
| Total Assets | $505.9M | - | - |
| Total Liabilities | $281.7M | - | - |
| Shareholders Equity | $216.3M | - | - |
| Operating Cash Flow | $-9.5M | - | - |
| Capital Expenditures | $796,000 | - | - |